Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05743855 · ClinicalTrials.gov registry record · NA

The Effect of Chiropractic Plus Nutritional Supplement in Patients With Chronic Pain and Inflammation.

A NA study of Chronic Pain and Inflammatory Response, sponsored by Standard Process.

Completed
Registry status
NA
Development phase
25
Enrollment target
3
Study locations

NCT05743855: Completed NA study of Chronic Pain and Inflammatory Response, sponsored by Standard Process.

NCT05743855 is a NA study of Chronic Pain and Inflammatory Response that has completed, run by Standard Process. The registered enrollment target is 25 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05743855, a NA study of Chronic Pain and Inflammatory Response, has completed, sponsored by Standard Process.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
3
Study locations

Study Summary

Evaluating the effect of a combined therapy of chiropractic sessions plus nutritional supplement containing hemp, omega-3 fatty acids, and broccoli extract oil in patients experiencing chronic pain and inflammation.

Primary Outcome

The BPI is a validated self-reporting instrument assessing pain. Possible score range 0-10 with higher scores indicating higher pain levels. The instrument contains 9 items.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Nutritional Supplement

Study Locations (3)

North Carolina

  • Randolph Chiropractic Health Center - Charlotte
  • Trull Chiropractic PA - Kannapolis
  • Combined Chiropractic & Acupuncture PLLC - Mooresville

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-03-28
Est. Completion 2022-04-01
Phase NA
Standard Process

8 total trials

What the finished NCT05743855 record still lists

NCT05743855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05743855 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05743855 about?

NCT05743855 is a clinical study titled "The Effect of Chiropractic Plus Nutritional Supplement in Patients With Chronic Pain and Inflammation.". Evaluating the effect of a combined therapy of chiropractic sessions plus nutritional supplement containing hemp, omega-3 fatty acids, and broccoli extract oil in patients experiencing chronic pain and inflammation.

What is the current status of trial NCT05743855?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-03-28. Estimated completion is 2022-04-01.

What conditions does trial NCT05743855 study?

This clinical trial studies the following conditions: Chronic Pain, Inflammatory Response.

What interventions are being tested in trial NCT05743855?

The interventions under investigation include: Placebo (OTHER), Nutritional Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05743855?

This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05743855 being conducted?

This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05743855's enrollment target sits among peer trials

25 257th of 301 higher than 39 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05743855, the US trial registry maintained by the National Library of Medicine. NCT05743855 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.